Loading clinical trials...
Loading clinical trials...
Effectiveness of Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
In the intervention group, LVB was performed with intima-to-intima coaptation using the super microsurgery technique. The anastomosis was between the afferent lymphatic vessel and the recipient vein. The upper extremity lymphedema (UEL) index and indocyanine green (ICG) lymphography are utilized to evaluate the progression of lymphedema.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Dharmais National Cancer Center
Jakarta, Jakarta Special Capital Region, Indonesia
Start Date
March 18, 2024
Primary Completion Date
March 21, 2027
Completion Date
March 21, 2028
Last Updated
November 18, 2025
136
ESTIMATED participants
Lymphovenous bypass (LVB)
PROCEDURE
Lead Sponsor
Dharmais National Cancer Center Hospital
NCT06532955
NCT04888975
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions